GeneDx (WGS) Is Still Growing in Core Testing, but the Guidance Reset Changed the Story

[ad_1] GeneDx Holdings Corp. (NASDAQ: WGS) did not report a collapsing business in its latest quarter. What it reported instead was a quarter that still showed healthy core test growth, but not enough revenue conversion to support the expectations investors…






